This page shows the details of why an item matched the keywords from your search.
| Item Type | Name |
|
Concept
|
Metabolic Syndrome
|
|
Academic Article
|
Efficacy and safety profile of fenofibrate-coated microgranules 130 mg, with and without food, in patients with hypertriglyceridemia and the metabolic syndrome: an 8-week, randomized, double-blind, placebo-controlled study.
|
|
Academic Article
|
Statin/fibrate combination in patients with metabolic syndrome or diabetes: evaluating the risks of pharmacokinetic drug interactions.
|
|
Academic Article
|
New concepts in dyslipidemia in the metabolic syndrome and diabetes.
|
|
Academic Article
|
Application of recent definitions of the metabolic syndrome to survey data from the National Cholesterol Education Program Evaluation Project Utilizing Novel E-Technology (NEPTUNE II).
|
|
Academic Article
|
Treating dyslipidemia in high-risk patients: case reviews and discussion.
|
|
Academic Article
|
Management of dyslipidemia in patients with complicated metabolic syndrome.
|
|
Academic Article
|
Low-density lipoprotein cholesterol reduction and goal achievement with ezetimibe/simvastatin versus atorvastatin or rosuvastatin in patients with diabetes, metabolic syndrome, or neither disease, stratified by National Cholesterol Education Program risk category.
|
|
Academic Article
|
Effects of fenofibrate on atherogenic dyslipidemia in hypertriglyceridemic subjects.
|
|
Academic Article
|
A clinical puzzle: fibrates and homocysteine elevation: editorial to: "fibrates may cause an abnormal urinary betaine loss which is associated with elevations in plasma homocysteine" by M. Lever et al.
|
|
Academic Article
|
Underappreciated opportunities for low-density lipoprotein management in patients with cardiometabolic residual risk.
|
|
Academic Article
|
The use of high-sensitivity assays for C-reactive protein in clinical practice.
|
|
Academic Article
|
Efficacy and safety of dalcetrapib in type 2 diabetes mellitus and/or metabolic syndrome patients, at high cardiovascular disease risk.
|
|
Academic Article
|
Effect of ezetimibe/simvastatin versus atorvastatin or rosuvastatin on modifying lipid profiles in patients with diabetes, metabolic syndrome, or neither: Results of two subgroup analyses.
|
|
Academic Article
|
Apolipoprotein measurements: is more widespread use clinically indicated?
|
|
Academic Article
|
Emerging therapeutic strategies for the management of dyslipidemia in patients with the metabolic syndrome.
|
|
Academic Article
|
A review of the current status of the management of mixed dyslipidemia associated with diabetes mellitus and metabolic syndrome.
|
|
Academic Article
|
Antipsychotic-induced weight gain and metabolic abnormalities: implications for increased mortality in patients with schizophrenia.
|